Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 18, 2014Journal of VirologyOpen Access

Severe Acute Respiratory Syndrome-Associated Coronavirus Vaccines Formulated with Delta Inulin Adjuvants Provide Enhanced Protection while Ameliorating Lung Eosinophilic Immunopathology

View Full Paper
Ask AI
Bookmark
Share

Authors

YHYoshikazu Honda‐OkuboSouth Australia PathologyDBDale L. BarnardTun Abdul Razak Research CentreCOChun Hao OngUniversiti Putra Malaysia

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Honda‐Okubo et al. (2014) studied this question.

synapsesocial.com/papers/6a196d56f2eb401dc78912f2https://doi.org/10.1128/jvi.02980-14
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1CpG Oligodeoxynucleotides Act as Adjuvants that Switch on T Helper 1 (Th1) Immunity1997 · 1,009 citations
  2. 2An Inactivated Cell Culture Japanese Encephalitis Vaccine (JE-ADVAX) Formulated with Delta Inulin Adjuvant Provides Robust Heterologous Protection against West Nile Encephalitis via Cross-Protective Memory B Cells and Neutralizing Antibody2013 · 78 citations
  3. 3Severe Acute Respiratory Syndrome Coronavirus Envelope Protein Ion Channel Activity Promotes Virus Fitness and Pathogenesis2014 · 593 citations
  4. 4Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus2006 · 162 citations
  5. 5CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus2004 · 633 citations